AB Molecular is pleased to present its latest case study, demonstrating first-hand experience one of our customers had working with us. Wrexham Maelor Hospital’s journey with the ePlex began in January 2020 as part of the Public Health Wales’ implementation …
Read MoreAuthor: annwebcom
Press Release: PHE Microbiology – Notification of Contract Award
AB Molecular’s bid for Lot 1 of the Public Health England National Microbiology Framework Agreement has been successful! Providing access to a range of in-vitro diagnostic medical devices and associated services including equipment, consumables, maintenance, and peripheral equipment and associated …
Read MoreMolecular syndromic test for COVID-19, influenza and other common respiratory pathogens helps health care professionals prepare for flu season
RP2 Panel at a Glance GenMark’s ePlex® Respiratory Pathogen Panel 2 (RP2) has achieved CE mark. RP2 provides results in less than two hours for more than 20 viruses and bacteria that cause common respiratory infections with similar symptoms, including …
Read MorePress Release: COVID-19 – Notification of Contract Award
AB Molecular’s bid for Lot 2 of the HealthTrust Europe COVID-19 Testing Framework Agreement has been successful! Comprehensive range of testing equipment, reagents, associated consumables and services for lab testing of COVID-19 included Molecular diagnostics multiplex syndromic respiratory panel and …
Read MoreGenMark ePlex system can now detect COVID-19
AB Molecular is pleased to announce the GenMark ePlex system can now detect COVID-19. The ePlex system can be used at point of care and in the laboratory. AB Molecular is the exclusive distributor in the UK for GenMarkDX for …
Read More
Introducing AB Molecular
AB Molecular Ltd is a newly formed joint venture company that has been set up in partnership between TCS Biosciences Ltd and AB Scientific Ltd. AB Molecular Ltd has been appointed as the exclusive UK distribution partner of GenMark Dx® and …
Read More